Dominari Holdings Inc. — Cyborg Score 6/10

Solid
Financial Services & Investment Banking

Strategic Profile

Dominari combines capital investment with management support, working closely with the executive teams of its subsidiaries to help them operate under a streamlined infrastructure and reduce costs. In February 2025, Donald Trump Jr. and Eric Trump joined the Company's Board of Advisors and participated in a private placement. The company is pivoting toward growth in emerging sectors with high-return potential.

Cyborg Score Rationale

Dominari demonstrates strategic repositioning from pharmaceuticals to financial services and emerging technologies. Recent high-profile advisory additions and focus on AI/data center investments signal confidence, but the company remains relatively small ($74.6M market cap) with limited operating history in its new sectors.

Top Insights

  • Transformed from a pharmaceutical company (AIkido Pharma) to a financial services and technology-focused holding company in December 2022, demonstrating significant strategic pivot
  • In August 2024, subsidiary Dominari Securities LLC received approval as a Nasdaq Limited Underwriting Member, enabling investment banking expansion
  • Company is pursuing direct investment in AI-driven assets and data center infrastructure to position itself at the forefront of AI-driven technologies and enhance shareholder value
  • Dominari Securities LLC seeks to create wealth for all stakeholders by capitalizing on emerging trends in the financial services sector and identifying early-stage future opportunities

Named Competitors

  • Goldman Sachs — Diversified investment banking and financial services
  • Morgan Stanley — Wealth management, investment banking, and trading
  • Lazard — Financial advisory and asset management services

Recent Developments

  • (February 2025) Donald Trump Jr. and Eric Trump joined Board of Advisors; company sharpened focus on data center and AI investment opportunities
  • (August 2024) Dominari Securities LLC approved as Nasdaq Limited Underwriting Member, enabling principal underwriting capabilities
  • (December 2022) Rebranded from AIkido Pharma Inc. to Dominari Holdings Inc., shifting strategic focus from healthcare to financial services

Open the full interactive Dominari Holdings Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →